Carbamazepine Prices June 2023
Product
|
Category |
Region |
Price |
Carbamazepine |
Pharma API |
India |
68690 USD/MT |
India’s PMI slightly decreased to 53.9 from 54.0 in May, indicating decreased purchasing activity and exporting momentum. Moreover, the Reserve Bank of India (RBI) responded to inflation concerns by raising interest rates twice in 2023. Consequently, carbamazepine prices were recorded at 68690 USD/MT, reflecting the evolving market dynamics and economic conditions during this period.
Carbamazepine Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Carbamazepine Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of carbamazepine pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of carbamazepine at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of carbamazepine price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing carbamazepine price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
![Carbamazepine Price Trend](https://www.imarcgroup.com/CKEditor/c36a4297-69b7-443f-9cbf-09f4685b9d26pricing-reports.webp)
Carbamazepine Market Analysis
The global carbamazepine market size reached US$ 736.9 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 987.0 Million, at a projected CAGR of 3.3% during 2023-2032.
- According to the 2024 report of the World Health Organization (WHO), around 50 million people worldwide have epilepsy. The growing prevalence of epilepsy worldwide is driving the demand for carbamazepine as a medication for epilepsy management.
- The carbamazepine demand is amplified by its utilization in the treatment of bipolar disorders, such as mood stabilization, manic episodes, depressive episodes, and maintenance therapy. It is also prescribed as a part of a comprehensive treatment plan tailored as per individual needs. As per the WHO report of 2022, 1 in 6 people worldwide will be aged 60 years or over by 2030. Moreover, the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion by 2030, and the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. The geriatric population is highly susceptible to neuropathy pain, which is driving the demand for carbamazepine.
- In addition, ongoing research and development (R&D) activities to improve drug delivery mechanism, such as novel delivery routes and extended-release formulations is bolstering the market growth.
- The market share is expanding due to the rising awareness among the masses about neurological and psychiatric disorders, coupled with improved diagnostics capabilities. Additionally, governing agencies in several countries are undertaking initiatives to improve healthcare infrastructure and increasingly access to vital medications are supporting the growth of the market.
- Carbamazepine production has also witnessed a considerable surge due to the widespread investment in the pharmaceutical drug delivery sector. The IMARC Group’s report shows that the global pharmaceutical drug delivery market is expected to reach US$ 2,157.1 Billion by 2032.
- The production of carbamazepine showed an upward trajectory owing to technological developments in pharmaceutical manufacturing processes to increase production efficiency and reduce costs. The growing number of pharmaceutical distribution networks, including online pharmacies and retail chains, is facilitating greater accessibility to carbamazepine.
Carbamazepine News
The report covers the latest developments, updates, and trends impacting the global carbamazepine market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in carbamazepine production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the carbamazepine price trend.
Latest developments in the carbamazepine industry:
- In 2024, Teva Pharmaceutical Investments Singapore Pte Ltd (TPIS) and Jiangsu Nhwa Pharmaceutical Co., Ltd announced a partnership for the marketing and distribution of Teva’s AUSTEDO for the treatment of neurodegenerative and movement disorders.
- In 2022, Apotex Inc., Canada's largest pharmaceutical company launched affordable generic option to treat relapsing remitting multiple sclerosiss (RRMS).
Product Description
Carbamazepine is a medication that belongs to the class of drugs known as anticonvulsants or antiepileptic drugs. It works by stabilizing electrical activity in the brain, which helps in preventing seizures and alleviates certain types of nerve pain. It is also prescribed for other conditions, such as bipolar disorder and trigeminal neuralgia. It is effective in managing a wide range of seizures, including partial, generalized tonic-clonic, and mixed seizures. It can assist in reducing the frequency and intensity of pain in conditions like diabetic neuropathy.
Moreover, carbamazepine is prescribed sometimes as a mood stabilizer for people with bipolar diseases. It can control mania and depression, leading to better mood stability and enhanced quality of life. It is also utilized off-label for certain conditions like schizophrenia and alcohol withdrawal syndrome.
Regional Coverage
The report provides a detailed analysis of the carbamazepine market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the carbamazepine price trend.
Global Carbamazepine Price
The report offers a holistic view of the global carbamazepine pricing trends in the form of carbamazepine price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of carbamazepine but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed carbamazepine demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Carbamazepine Price
In Europe, the prices for carbamazepine witnessed an upward trajectory during the second quarter of 2023. This trend can be attributed to the wide availability of carbamazepine in the exporting nations like India. However, the prices declined in June while maintaining a balance between supply and demand of the material. Disrupted supply chains also contributed to declined prices of carbamazepine in the region.
Throughout the first quarter of 2024, the market in Europe experienced a significant downturn, reflecting a wider reduction in prices and market sentiment. This trend was mainly driven by strategic decisions made in Germany, a notable importing hub whose strategies regrading prices had a ripple effect across the region. However, other factors contributed to shaping market dynamics in the Germany during this period.
This analysis can be extended to include detailed carbamazepine price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Carbamazepine Price
The price of carbamazepine in the North America region experienced an upward trend during the second quarter of 2023. This trend can be attributed to the high demand from the pharmaceutical and healthcare industries in the region. Key players operating in these industries benefitted by charging more for their goods. However, as June approached, the prices of carbamazepine decreased sharply in the region.
In the first quarter of 2024, the carbamazepine market price in North America experienced a notable decline due to price fluctuations influenced by several aspects. This downturn is mainly driven by strategic actions taken by the USA, a key importer of carbamazepine. The USA adjusted its strategies regarding prices to improve competitiveness around the world, causing a ruffled effects worldwide, which led to reductions in prices.
Specific carbamazepine historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Carbamazepine Price
The report explores the carbamazepine pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on carbamazepine prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Carbamazepine Price
The carbamazepine market in the Asia Pacific region witnessed increased prices during the second quarter of 2023. This region also experienced moderate inquiries from the domestic and international markets. In June 2023, the Purchasing Managers' Index (PMI) for India was 53.9, which is less than May 2023. Although the manufacturing PMI fell in April, as key players had enough inventories to cater to the demand of the domestic market.
During the first quarter of 2024, in the Asia Pacific region the market witnessed a downward trend, a reduction compared to the previous year quarter. This decline was influenced by multiple aspects, such as restrained demand from downstream industries, a weakened economy across the globe, and heightened competition in the market. In India, the largest market for carbamazepine in the region, exhibited notable fluctuations in the price due to reduced demand and surplus inventory.
This carbamazepine price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Carbamazepine Price
The analysis of carbamazepine prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Carbamazepine |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Carbamazepine Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of carbamazepine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting carbamazepine price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The carbamazepine price charts ensure our clients remain at the forefront of the industry.